The EOL-1 Cell Line as an in Vitro Model for the Study of FIP1L1-PDGFRA-positive Chronic Eosinophilic Leukemia

Blood - United States
doi 10.1182/blood-2003-07-2479
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukaemia and Associated Central Nervous System Involvement

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2008English

Induction of Myeloperoxidase and Nitrotyrosine Formation in a Human Eosinophilic Leukemia Cell Line, EoL-1

Cell Biochemistry and Function
BiochemistryMedicineClinical BiochemistryCell Biology
2004English

Eosinophilic Differentiation of the Human Promyelocytic Leukemia Cell Line, HL-60

Journal of Experimental Medicine
MedicineAllergyImmunology
1984English

Diagnostic Challenges During Pretreatment Long-Term Follow-Up in a Patient With FIP1L1-PDGFRA-positive Eosinophilia

Internal Medicine
Internal MedicineMedicine
2015English

FIP1L1-PDGFRα D842V, a Novel Panresistant Mutant, Emerging After Treatment of FIP1L1-PDGFRα T674I Eosinophilic Leukemia With Single Agent Sorafenib

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

MOVAS-1 Cell Line: A New in Vitro Model of Vascular Calcification

International Journal of Molecular Medicine
MedicineGenetics
2011English

Markers of Tyrosine Kinase Activity in Eosinophilic Esophagitis: A Pilot Study of the FIP1L1-PDGFRα Fusion Gene, pERK 1/2, and pSTAT5

Diseases of the Esophagus
MedicineGastroenterology
2011English

Low Frequency of DNMT3A Mutations in Pediatric AML, and the Identification of the OCI-AML3 Cell Line as an in Vitro Model

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

ETV6-PDGFRB and FIP1L1-PDGFRA Stimulate Human Hematopoietic Progenitor Cell Proliferation and Differentiation Into Eosinophils: The Role of Nuclear Factor- B

Haematologica
Hematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy